Tiziana Life Sciences Ltd
TLSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723069
In the last 90 days, Tiziana Life Sciences Ltd insiders filed 4 open-market purchases and 0 sales; 30 institutions reported holding it in 13F filings for Q2 2026, worth $3.10M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Tiziana Life Sciences Ltd changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 23 | 18 | −5 |
| Shares | 5.28M | 1.08M | −4.20M (−79.6%) |
| Value | $3.17M | $1.15M | −$2.02M (−63.7%) |
New holders (1)
Institutions that held Tiziana Life Sciences Ltd at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| JNBA Financial Advisors | 2,000 | $2.18K | 0.00% |
Sold out (6)
Institutions that held Tiziana Life Sciences Ltd at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| HighTower Advisors, LLC | 4,130,001 | $2.47M |
| Susquehanna International Group, LLP | 39,193 | $23.7K |
| IFP Advisors, Inc | 1,698 | $3.00K |
| Credit Suisse AG | 2,960 | $1.79K |
| Money Concepts Capital Corp | 100 | $60 |
| Simplex Trading, LLC | 465 | $0 |